Top compounds associated with response to USP17L11


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA tandutinib CTRPv2 pan-cancer AAC -0.035 0.3
mRNA PD318088 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.028 0.3
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC -0.049 0.3
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.031 0.3
Download CSV